NEW YORK, March 26 - The largest manufacturer of medical devices at the center of recent superbug outbreaks in the U.S. issued an "urgent safety notification" to health providers on Thursday, detailing new procedures for disinfecting the equipment and urging them to adopt the procedures "as soon as possible."
March 26 - Surgery Partners LLC is preparing for an initial public offering (IPO) in the summer that could value the private equity-owned surgical center manager at about $2 billion, including debt, according to people familiar with the matter.
March 26 - French drugmaker Genfit SA said on Thursday it will begin a late stage trial later this year of its lead treatment for a liver-destroying condition, saying it failed a midstage trial in part due to its inclusion of many patients with a mild form of the disease.
WASHINGTON, March 26 - There is no sign the Ebola virus is mutating in an accelerated way that could make it more virulent or thwart vaccines or drugs under development despite some earlier fears to the contrary, researchers said on Thursday.
* Objective to raise up to 9.9 percent of current share capital to fund research and development and for general corporate purposes
No related earnings announcements are currently scheduled within the next 7 days.